These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

637 related items for PubMed ID: 9001896

  • 1. Renal effects of angiotensin II receptor blockade and angiotensin-converting enzyme inhibition in healthy subjects.
    Burnier M, Brunner HR.
    Exp Nephrol; 1996; 4 Suppl 1():41-6. PubMed ID: 9001896
    [Abstract] [Full Text] [Related]

  • 2. The advantages of angiotensin II antagonism.
    Burnier M, Waeber B, Brunner HR.
    J Hypertens Suppl; 1994 Jul; 12(2):S7-15. PubMed ID: 7965267
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin II blockade compared with other pharmacological methods of inhibiting the renin-angiotensin system.
    Brunner HR, Nussberger J, Waeber B.
    J Hypertens Suppl; 1993 Apr; 11(3):S53-8. PubMed ID: 8315521
    [Abstract] [Full Text] [Related]

  • 4. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
    Dahlöf B.
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480
    [Abstract] [Full Text] [Related]

  • 5. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
    Murakami M, Suzuki H, Naitoh M, Matsumoto A, Kageyama Y, Tsujimoto G, Saruta T.
    J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
    [Abstract] [Full Text] [Related]

  • 6. The future role of losartan.
    Hansson L.
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S55-8. PubMed ID: 8583483
    [Abstract] [Full Text] [Related]

  • 7. Angiotensin II receptor antagonists versus angiotensin converting enzyme inhibitors: effects on renal function.
    Jover B, Mimran A.
    J Hypertens Suppl; 1994 Nov; 12(9):S3-9. PubMed ID: 7884582
    [Abstract] [Full Text] [Related]

  • 8. Renal effects of angiotensin I-receptor blockade and angiotensin convertase inhibition in man.
    Schmitt F, Natov S, Martinez F, Lacour B, Hannedouche TP.
    Clin Sci (Lond); 1996 Mar; 90(3):205-13. PubMed ID: 8777826
    [Abstract] [Full Text] [Related]

  • 9. Renin inhibitors, angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists: relationships between blood pressure responses and effects on the renin-angiotensin system.
    Schalekamp MA, Derkx FH, van den Meiracker AH.
    J Hypertens Suppl; 1992 Dec; 10(7):S157-64. PubMed ID: 1291650
    [Abstract] [Full Text] [Related]

  • 10. Studies of the renal effects of angiotensin II receptor blockade: the confounding factor of acute water loading on the action of vasoactive systems.
    Burnier M, Pechère-Bertschi A, Nussberger J, Waeber B, Brunner HR.
    Am J Kidney Dis; 1995 Jul; 26(1):108-15. PubMed ID: 7611241
    [Abstract] [Full Text] [Related]

  • 11. Localization of components of the renin-angiotensin system and site of action of inhibitors.
    Chai SY, Zhuo J, Mendelsohn FA.
    Arzneimittelforschung; 1993 Feb; 43(2A):214-21. PubMed ID: 8498967
    [Abstract] [Full Text] [Related]

  • 12. A new class of therapeutic agents: the angiotensin II receptor antagonists.
    Timmermans PB, Smith RD.
    Cardiologia; 1994 Dec; 39(12 Suppl 1):397-400. PubMed ID: 7634303
    [Abstract] [Full Text] [Related]

  • 13. Effects of the specific angiotensin II receptor antagonist losartan on urate homeostasis and intestinal urate transport.
    Hatch M, Freel RW, Shahinfar S, Vaziri ND.
    J Pharmacol Exp Ther; 1996 Jan; 276(1):187-93. PubMed ID: 8558429
    [Abstract] [Full Text] [Related]

  • 14. Discovery of losartan, the first angiotensin II receptor antagonist.
    Timmermans PB, Duncia JV, Carini DJ, Chiu AT, Wong PC, Wexler RR, Smith RD.
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S3-18. PubMed ID: 8583479
    [Abstract] [Full Text] [Related]

  • 15. Modulation of the renin-angiotensin-aldosterone system and cough.
    Lacourcière Y, Lefebvre J.
    Can J Cardiol; 1995 Aug; 11 Suppl F():33F-39F. PubMed ID: 7664216
    [Abstract] [Full Text] [Related]

  • 16. The diversified pharmacology of angiotensin II-receptor blockade.
    Timmermans PB, Smith RD.
    Blood Press Suppl; 1996 Aug; 2():53-61. PubMed ID: 8913541
    [Abstract] [Full Text] [Related]

  • 17. Angiotensin II antagonists: a new class of antihypertensive agent.
    Waeber B, Brunner HR.
    Br J Clin Pract; 1996 Aug; 50(5):265-8. PubMed ID: 8794603
    [Abstract] [Full Text] [Related]

  • 18. Differential effects of oral losartan and enalapril on local venous and systemic pressor responses to angiotensin I and II in healthy men.
    Goldberg MR, de Mey C, Wroblewski JM, Li Q, Schroeter V, Belz GG.
    Clin Pharmacol Ther; 1996 Jan; 59(1):72-82. PubMed ID: 8549037
    [Abstract] [Full Text] [Related]

  • 19. Angiotensin II type 1 receptor blockade: a new development in cardiovascular pharmacology.
    Leary AC, MacDonald TM.
    Int J Clin Pract; 1998 Oct; 52(7):475-81. PubMed ID: 10622089
    [Abstract] [Full Text] [Related]

  • 20. Clinical pharmacology of angiotensin and bradykinin in human forearm vasculature.
    Ritter JM, Cockcroft JR, Sciberras DG, Goldberg MR.
    J Hypertens Suppl; 1993 Apr; 11(3):S59-61. PubMed ID: 8391072
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.